End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 BGN | -.--% | -.--% | +1.75% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 133.1 | 138.1 | 125.1 | 175.6 | 206.3 | 187.7 |
Enterprise Value (EV) 1 | 149.7 | 151.2 | 134.1 | 181.7 | 209 | 186.2 |
P/E ratio | 19.6 x | 18.9 x | 17.5 x | 19.4 x | 20.1 x | 15.9 x |
Yield | 4.22% | 4.4% | 2.88% | 2.08% | 1.76% | - |
Capitalization / Revenue | 12.5 x | 12.4 x | 11.4 x | 16.7 x | 19.3 x | 15.4 x |
EV / Revenue | 14 x | 13.6 x | 12.2 x | 17.3 x | 19.5 x | 15.3 x |
EV / EBITDA | 22.4 x | 21.3 x | 18.8 x | 25.1 x | 30.7 x | 23.5 x |
EV / FCF | 46.5 x | 36.6 x | 28.6 x | 46 x | 52.6 x | 39.8 x |
FCF Yield | 2.15% | 2.73% | 3.5% | 2.17% | 1.9% | 2.51% |
Price to Book | 2.31 x | 2.24 x | 1.91 x | 2.39 x | 2.57 x | 2.12 x |
Nbr of stocks (in thousands) | 20,954 | 21,416 | 21,951 | 21,951 | 21,951 | 21,951 |
Reference price 2 | 6.350 | 6.450 | 5.700 | 8.000 | 9.400 | 8.550 |
Announcement Date | 3/29/19 | 1/30/20 | 1/29/21 | 1/31/22 | 3/23/23 | 1/30/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 10.66 | 11.15 | 11.01 | 10.51 | 10.69 | 12.19 |
EBITDA 1 | 6.676 | 7.084 | 7.132 | 7.253 | 6.817 | 7.93 |
EBIT 1 | 6.671 | 7.079 | 7.127 | 7.247 | 6.807 | 7.921 |
Operating Margin | 62.56% | 63.48% | 64.73% | 68.95% | 63.68% | 64.97% |
Earnings before Tax (EBT) 1 | 6.614 | 7.187 | 7.011 | 9.071 | 10.27 | 11.83 |
Net income 1 | 6.614 | 7.187 | 7.011 | 9.071 | 10.27 | 11.83 |
Net margin | 62.02% | 64.45% | 63.67% | 86.31% | 96.04% | 97.05% |
EPS 2 | 0.3246 | 0.3405 | 0.3252 | 0.4132 | 0.4677 | 0.5390 |
Free Cash Flow 1 | 3.222 | 4.134 | 4.69 | 3.949 | 3.974 | 4.679 |
FCF margin | 30.21% | 37.07% | 42.59% | 37.58% | 37.17% | 38.38% |
FCF Conversion (EBITDA) | 48.26% | 58.35% | 65.76% | 54.45% | 58.29% | 59.01% |
FCF Conversion (Net income) | 48.71% | 57.52% | 66.89% | 43.54% | 38.7% | 39.55% |
Dividend per Share 2 | 0.2680 | 0.2840 | 0.1640 | 0.1660 | 0.1650 | - |
Announcement Date | 3/29/19 | 1/30/20 | 1/29/21 | 1/31/22 | 3/23/23 | 1/30/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 16.7 | 13.1 | 9.03 | 6.08 | 2.64 | - |
Net Cash position 1 | - | - | - | - | - | 1.47 |
Leverage (Debt/EBITDA) | 2.495 x | 1.848 x | 1.266 x | 0.8385 x | 0.3876 x | - |
Free Cash Flow 1 | 3.22 | 4.13 | 4.69 | 3.95 | 3.97 | 4.68 |
ROE (net income / shareholders' equity) | 12.2% | 12.1% | 11% | 12.8% | 13.3% | 14% |
ROA (Net income/ Total Assets) | 4.94% | 5.2% | 5.16% | 5.16% | 4.7% | 5.24% |
Assets 1 | 133.9 | 138.2 | 135.8 | 175.8 | 218.5 | 225.8 |
Book Value Per Share 2 | 2.750 | 2.880 | 2.980 | 3.350 | 3.660 | 4.040 |
Cash Flow per Share 2 | 0.0100 | 0.0300 | 0.0800 | 0.0700 | 0.0900 | 0.0900 |
Capex 1 | 0.03 | 0.15 | 0.03 | 0.11 | 0.01 | - |
Capex / Sales | 0.32% | 1.31% | 0.31% | 1.02% | 0.06% | - |
Announcement Date | 3/29/19 | 1/30/20 | 1/29/21 | 1/31/22 | 3/23/23 | 1/30/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+1.75% | 104M | |
-15.71% | 12B | |
-12.81% | 7.58B | |
-7.99% | 5.46B | |
-1.44% | 5.28B | |
-10.99% | 5.25B | |
+3.09% | 4.62B | |
-7.27% | 4.52B | |
-2.70% | 4.51B | |
+5.20% | 3.91B |
- Stock Market
- Equities
- SFI Stock
- Financials Sopharma Properties REIT